Iodine Deficiency Drug Market Expected To Reach $6.5 Billion By 2031 | Allied Market Research


(MENAFN- EIN Presswire)

The global iodine deficiency drug market size is projected to reach $6.5 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031.

PORTLAND, OREGON, UNITED STATES, May 26, 2023 /einpresswire.com / -- Iodine deficiency is a condition that occurs when the body does not have enough iodine, a trace mineral essential for the production of thyroid hormones. In regions where iodine deficiency is prevalent, the use of iodine supplements or iodized salt can help prevent and treat this condition. Iodine supplements, such as potassium iodide or iodine drops, are available in various formulations and are typically taken orally. The global iodine deficiency drug market size was valued at $3.7 billion in 2021, and is projected to reach $6.5 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031.

♦ Download Free Sample PDF Of This Report:

Iodized salt is a commonly used approach to prevent iodine deficiency. It is regular table salt that has been fortified with iodine. By incorporating iodized salt into the diet, individuals can ensure an adequate intake of iodine. It is important to note that iodine supplements and iodized salt should be used under the guidance of a healthcare professional to avoid excessive iodine intake, which can also have adverse effects.

Major market players covered in the report, such as -

Cipla Ltd,

Abbott Laboratories,

Abbvie Inc,

Fresenius SE and Co. KGaA,

Glaxosmithkline plc,

Lupin Ltd,

Merck KGaA,

Pfizer Inc.,

Teva Pharmaceutical Industries Ltd.,

Macleods Pharmaceuticals Ltd

♦ Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @

Key Benefits for Stakeholders -

. The report provides quantitative analysis of market segments, current trends, strategies and potential of Iodine Deficiency Drug Market research to identify potential Iodine Deficiency Drug Market opportunities in genetics.
. In-depth analysis of this sector helps identify current market opportunities.
. Market analysis and information related to key drivers, restraints and opportunities are provided. . Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
. The largest countries in each region are listed according to their contribution to the global market.
. Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
. The report includes regional and global Iodine Deficiency Drug Market analysis, key players, market segments, application areas and Market growth strategies.

In severe cases of iodine deficiency, where individuals may develop an enlarged thyroid gland (known as a goiter) or experience thyroid dysfunction, additional medical treatment may be necessary. This can involve the administration of thyroid hormone replacement therapy to restore normal thyroid function and address related symptoms.

Overall, the primary approach to managing iodine deficiency involves ensuring an adequate intake of iodine through the use of iodine supplements or iodized salt, while carefully monitoring iodine levels to maintain a balance that supports optimal thyroid function.

The Iodine Deficiency Drug Market is expected to witness a significant growth in the coming years. This market has gained interest of the healthcare and medical sectors owing to increased prevalence of hypertension throughout the globe. Furthermore, the global Iodine Deficiency Drug Market is segmented on the basis of product type, end user, and region. leading market players have been introducing various strategies to help enterprises move their on-premise models to on-demand models.

♦ For Purchase Enquiry -

Frequently Asked Questions?

Q1. What is the total market value of Iodine Deficiency Drug Market report?

Q2. Which are the top companies holding the market share in Iodine Deficiency Drug Market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of Iodine Deficiency Drug Market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the Iodine Deficiency Drug Market report?

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here

MENAFN26052023003118003196ID1106320895


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.